)
)
Syros Pharmaceuticals Investor Relations Material
Latest events
Q3 2024
Syros Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Syros Pharmaceuticals Inc
Access all reports
Syros Pharmaceuticals Inc. is a biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. The company uses its proprietary gene control platform to identify and develop small-molecule drugs that modulate the expression of specific genes associated with disease. Syros's pipeline includes investigational treatments for hematologic cancers, solid tumors, and other genetically defined diseases. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Syros Pharmaceuticals Inc
Corporate Presentation
Syros Pharmaceuticals Inc
Status Update
Syros Pharmaceuticals Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
SYRS
Country
🇺🇸 United States